LBRX

LB Pharmaceuticals
LBRX

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$35
65% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Stifel
Stifel
Paul Matteis
50% 1-yr LBRX win rate
11 Dec ‘25 1 month ago